Worth reading
49Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Deterioration
Direction inferred from the company’s description.Scale
-0.4
% (year-on-year change in revenue)Wording
Conditional
How definitive the wording is.Results for this period
First quarter1 June 2026 to 31 August 2026ConsolidatedJapanese GAAPNet Sales1,554¥ millionYear on year -0.4%Progress 22.2%
Operating profit-21¥ million
Ordinary income-36¥ million
Net income attributable to owners of the parent-42¥ million
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share-¥4.67
Financial position at period-end
Total assets4,380¥ million
of which net assets 2,002 ¥ millionEquity ratio 43.9%vs. prior year-end +0.3pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Segment revenue
Media and Platform Business206,91713.3%-18.8%
Healthcare Institution Management Support Business1,171,44075.4%+1.7%
Medical B2B Business70,8314.6%+113.5%
Cloud Integration Business105,1646.8%-14.6%
Other2250.0%+400.0%
Segment profit
Media and Platform Business74,75064.3%-40.8%
Healthcare Institution Management Support Business10,3648.9%-17.3%
Medical B2B Business12,23710.5%
Cloud Integration Business18,75516.1%-26.5%
Other2250.2%+400.0%
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥7,000 million (YoY +4.0%)
Operating profit¥300 million (YoY +56.5%)
Ordinary income¥277 million (YoY +2.5%)
Profit attributable to owners of the parent¥146 million (YoY +5.9%)
Annual Dividend Forecast¥3 → ¥3（0.0%）
Factors Behind Changes in Business Performance
Sluggish advertising spending in the media business, lower profit margins and the shift from foreign exchange gains to foreign exchange losses contributed to the decline in profit. Meanwhile, the medical BtoB business returned to profitability as a result of winning large-scale practice-opening projects and increased sales of high-margin services.
Disclosure regarding the going concern assumption
No applicable matters.
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew 0 / Excluded 0 / Company name No applicable matters
Material subsequent eventsDisposal of treasury shares through a third-party allotment. 411,500 common shares were disposed of on 15 September 2026 at ¥243 per share, for a total disposal price of ¥99,994,500., OKAMURA CORPORATION resolved to acquire all shares of 有限会社板倉歯科器材店, making it a sub-subsidiary.
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of non-current assets ¥387 thousand / Extraordinary loss Not disclosed
Depreciation and amortization¥6,662 thousand
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingWhether applicable No / Subject person Not disclosed
Issued Shares at Period-End10,773,000
Treasury Shares at Period-End1,598,030
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 June 2026 to 31 August 2026 |
| Net Sales | ¥1,554 million (YoY -0.4%) |
| Operating profit | ¥-21 million |
| Ordinary income | ¥-36 million |
| Profit attributable to owners of the parent | ¥-42 million |
| Net income per share | -¥4.67 |
| Equity ratio | End of the current fiscal period 43.9% / End of previous period 43.6% |
| Total assets | ¥4,380 million |
| Net assets | ¥2,002 million |
| Full-year earnings forecast | Net Sales ¥7,000 million (YoY +4.0%) / Operating profit ¥300 million (YoY +56.5%) / Ordinary income ¥277 million (YoY +2.5%) / Profit attributable to owners of the parent ¥146 million (YoY +5.9%) |
| Annual Dividend Forecast | ¥3 → ¥3（0.0%） |
| Segment revenue | Media and Platform Business ¥206,917 thousand (YoY -18.8%) / Healthcare Institution Management Support Business ¥1,171,440 thousand (YoY +1.7%) / Medical B2B Business ¥70,831 thousand (YoY +113.5%) / Cloud Integration Business ¥105,164 thousand (YoY -14.6%) / Other ¥225 thousand (YoY +400.0%) |
| Segment profit | Media and Platform Business ¥74,750 thousand (YoY -40.8%) / Healthcare Institution Management Support Business ¥10,364 thousand (YoY -17.3%) / Medical B2B Business ¥12,237 thousand / Cloud Integration Business ¥18,755 thousand (YoY -26.5%) / Other ¥225 thousand (YoY +400.0%) |
| Depreciation and amortization | ¥6,662 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥387 thousand / Extraordinary loss Not disclosed |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 / Excluded 0 / Company name No applicable matters |
| Material subsequent events | Disposal of treasury shares through a third-party allotment. 411,500 common shares were disposed of on 15 September 2026 at ¥243 per share, for a total disposal price of ¥99,994,500., OKAMURA CORPORATION resolved to acquire all shares of 有限会社板倉歯科器材店, making it a sub-subsidiary. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable No / Subject person Not disclosed |
| Issued Shares at Period-End | 10,773,000 |
| Treasury Shares at Period-End | 1,598,030 |
| Factors Behind Changes in Business Performance | Sluggish advertising spending in the media business, lower profit margins and the shift from foreign exchange gains to foreign exchange losses contributed to the decline in profit. Meanwhile, the medical BtoB business returned to profitability as a result of winning large-scale practice-opening projects and increased sales of high-margin services. |
Items this document does not state (11)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicyRegional salesOrders received and order backlogImpairment loss
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Advertising spending in the media business remained sluggish, resulting in a decline in the profit margin. The shift from a foreign exchange gain in the same period of the previous year to a foreign exchange loss in the current period also contributed to the decline in profit.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.